Ascentage Pharma Group Internat (AAPG) Financials

$28.28

$0.53 (1.91%)
Last update: 04:00 PM EST
Day's range
$28.24
Day's range
$28.68
$1B$1B$500M$500M$0$0-$500M-$500M-$1B-$1B-$1.5B-$1.5BEarning201820182019201920202020202120212022202220232023202420240%0%-5000%-5000%-10000%-10000%-15000%-15000%-20000%-20000%-25000%-25000%Profit Margin
Profit Margin
Revenue
Earnings

AAPG Income statement / Annual

Last year (2024), Ascentage Pharma Group International's total revenue was $980.65 M, an increase of 341.77% from the previous year. In 2024, Ascentage Pharma Group International's net income was -$405.43 M. See Ascentage Pharma Group International,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $980.65 M $221.98 M $209.71 M $4.33 M $12.45 M $14.51 M $6.81 M $6.33 M $7.67 M
Cost of Revenue $29.09 M $30.54 M $22.00 M $3.33 M $1.97 M $2.10 M $0.00 $0.00 $261,000.00
Gross Profit $951.57 M $191.44 M $187.71 M $24.58 M $10.48 M $12.42 M $6.81 M $6.33 M $7.41 M
Gross Profit Ratio 0.97 0.86 0.9 5.68 0.84 0.86 1 1 0.97
Research and Development Expenses $947.25 M $706.97 M $743.10 M $766.49 M $564.57 M $463.88 M $249.57 M $118.82 M $102.69 M
General & Administrative Expenses $187.13 M $181.08 M $170.60 M $143.51 M $62.69 M $98.85 M $89.72 M $13.41 M $17.71 M
Selling & Marketing Expenses $196.00 M $195.39 M $157.42 M $47.75 M $1.37 M $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $383.12 M $376.46 M $328.02 M $191.26 M $64.06 M $98.85 M $12.64 M $13.41 M $17.71 M
Other Expenses -$9.07 M -$19.36 M -$33.60 M -$63.34 M $45.80 M $32.37 M -$8.63 M $4.78 M $1.63 M
Operating Expenses $1.32 B $1.06 B $1.04 B $894.42 M $674.43 M $595.10 M $330.65 M $137.00 M $122.03 M
Cost And Expenses $1.35 B $1.09 B $1.06 B $897.75 M $676.39 M $597.20 M $330.65 M $137.00 M $122.29 M
Interest Income $37.84 M $4.57 M $9.73 M $7.11 M $5.22 M $12.91 M $7.06 M $304,000.00 $13,000.00
Interest Expense $64.46 M $96.06 M $52.79 M $16.73 M $6.26 M $4.27 M $36.92 M $57.94 M $3.26 M
Depreciation & Amortization $93.17 M $93.20 M $9.13 M $4.39 M $3.97 M $3.83 M $18.46 M $12.50 M $164,369.00
EBITDA -$237.63 M -$743.61 M -$771.47 M -$787.19 M -$641.77 M -$1.45 B -$291.53 M -$49.68 M -$103.03 M
EBITDA Ratio -0.24 -3.35 -3.68 -181.9 -51.55 -100.02 -42.83 -7.85 -13.44
Operating Income Ratio -0.38 -3.93 -4.05 -201 -53.33 -40.15 -7.38 -20.65 -14.95
Total Other Income/Expenses Net -$25.53 M -$60.23 M -$37.36 M $37.59 M -$11.51 M -$899.63 M -$23.07 M $10.55 M $6.78 M
Income Before Tax -$395.26 M -$932.86 M -$887.17 M -$832.25 M -$675.45 M -$1.48 B -$346.91 M -$120.12 M -$107.84 M
Income Before Tax Ratio -0.4 -4.2 -4.23 -192.31 -54.25 -102.14 -50.96 -18.98 -14.07
Income Tax Expense $10.43 M -$7.15 M -$4.25 M -$49.83 M $2.16 M -$1.60 M -$1.60 M -$1.60 M $0.00
Net Income -$405.43 M -$925.64 M -$882.92 M -$782.42 M -$677.61 M -$1.48 B -$345.31 M -$118.51 M -$107.84 M
Net Income Ratio -0.41 -4.17 -4.21 -180.8 -54.43 -102.03 -50.73 -18.73 -14.07
EPS -0.746 -13.12 -13.4 -12.28 -12.56 -50.76 -6.67 -2.29 -2.08
EPS Diluted -0.746 -13.12 -13.4 -12.28 -12.56 -50.76 -6.67 -2.29 -2.08
Weighted Average Shares Out $75.52 M $70.57 M $65.92 M $63.65 M $53.98 M $29.18 M $51.77 M $51.77 M $51.77 M
Weighted Average Shares Out Diluted $75.52 M $70.57 M $65.92 M $63.65 M $53.98 M $29.18 M $51.77 M $51.77 M $51.77 M
Link